Clinical Trials in Austin

Showing 501-520 of 13,060 trials

A Study to Assess Adults With CIDP Transitioning From IVIg to Efgartigimod PH20 SC

NCT06637072

This study will measure how adults with CIDP receiving IVIg treatment adjust to efgartigimod PH20 SC. The study duration for each participant will be approximately 17 to 19 weeks.

Chronic Inflammatory Demyelinating Polyneuropathy

argenx23 participantsStarted Dec 2024

Washington D.C., District of Columbia, United States • Maitland, Florida, United States • Miami, Florida, United States +10 more locations

COMPLETEDNA< 1 mile

Women's Heart Attack Research Program: Stress Ancillary Study

NCT02914483

The Women's HARP study is a multi-center study focusing on women with clinical presentation of myocardial infarction (MI). Women will complete stress questionnaires following presentation to the medical center with elevated cardiac enzymes and abnormal electrocardiograms (ECGs). 2 months following MI, participants will be screened for the Stress Ancillary Study and enrolled if an elevated level of perceived stress is reported. After completing baseline assessments, participants will be randomized to Enhanced Usual Care (EUC) or stress management for 8 weeks. Participants will be followed for 6 months.

Myocardial Infarction

NYU Langone Health153 participantsStarted Jan 2017

Los Angeles, California, United States • Gainesville, Florida, United States • Atlanta, Georgia, United States +11 more locations

A Study to Assess Adults With CIDP Transitioning From IVIg to Efgartigimod PH20 SC

Women's Heart Attack Research Program: Stress Ancillary Study

Find Trials by Condition in Austin

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

SteRilizing Eye SoLution to ImprovE Patient ComFort (RELIEF)

A First-in-Human Study of BGB-C354 Alone and in Combination With Tislelizumab in Participants With Advanced Solid Tumors

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection

RCT to Evaluate Social Skills in Children With Autism Using VR Technology (SoCaVR)

First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours

TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention

A Global Study to Assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer

AB-101 as Monotherapy and With Immunotherapy in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)

A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma

A Study of DB-1310 in Advanced/Metastatic Solid Tumors

Real World Evidence Study in Subjects With Wilson's Disease

Can Intraosseous Antibiotics Improve the Results of Irrigation & Debridement and Prosthetic Retention for PJI?

A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration